Radius FracturesPhase 4NCT00274378
Allomatrix Injectable Putty in Distal Radius Fractures
A Phase 4 study testing ALLOMATRIX injectable putty in distal radius fractures in people with Radius Fractures, run by Université Catholique de Louvain at 1 site in Belgium.
Trial summary
Allomatrix is a combination of Demineralized Bone Matrix with a binding medium of calcium sulfate hemihydrate and carboxymethylcellulose. Allomatrix combines the osteoinductive capacity of DBM with the osteoconduction and controlled resorption of surgical grade calcium sulfate. Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Radius Fractures
- What is being tested?
- ALLOMATRIX injectable putty in distal radius fractures
- Type of treatment
- Injection or infusion, Medical device
- How many people
- 50 participants
- Where
- 1 siteBelgium
- Study dates
- Jun 2005to May 2009
- Phase
- Phase 4
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- unstable distal radius fracture
Who cannot join
- associated traumatic lesions
- associated severe pathological conditions
- pregnancy
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Allomatrix Injectable Putty in Distal Radius Fractures. Protocol for a Randomised, Controlled Clinical Study in Unstable Fractures of the Distal Radius
Allomatrix is a combination of Demineralized Bone Matrix with a binding medium of calcium sulfate hemihydrate and carboxymethylcellulose. Allomatrix combines the osteoinductive capacity of DBM with the osteoconduction and controlled resorption of surgical grade calcium sulfate.
Unstable fractures of the distal radius do not resist displacement once it has been manipulated into an anatomical position.
Read more
There is a parallel between the quality of the anatomic result and the residual capacity of the wrist, except in older, low demanding patients.
Injectable osteoconductive cements have been introduced to fill voids in metaphyseal bone and may provide a better stability around hardware in osteoporotic bone and help maintain reduction of fracture fragments.Moreover, a product like ALLOMATRIX could accelerate and improve bone healing and fracture stability by its osteoinductive properties. However, the clinical significance of these new bone graft materials still have to be proven in a randomised controlled study set-up.
Read the detailed description
STUDY DESIGN
The study is designed as a randomised, prospective, study with concurrent control. A total of 50 patients will be enrolled by one centre and will be randomised into two groups. One group of patients (comprising 50% of the study population) will have ALLOMATRIX Injectable Putty implanted. In a control group of patients (comprising 50% of the study population as well ) no graft material will be used.
Patients will be randomly assigned to one of the two treatment arms. Sequentially numbered randomisation envelopes will be provided. Once the surgical reduction and stabilisation has been completed, the next sequentially numbered randomisation envelope will be opened and the patient will receive the treatment listed within the envelope. Each envelope will contain one of the treatment arms based on a computer generated randomised schedule.
DURATION AND ENDPOINTS OF THE STUDY The enrollment period is expected to be about 3 years. Patients will be followed from a pre-operative visit through a one-year visit.
Study End Points:
- Comparison of time to healing of the fracture
- Comparison of function of operated wrist
- Radiographic and densitometric assessment of bone regeneration
- Failure rates (Non-union, malunion, fracture instability, wrist stiffness)
- Complication rates (infection, drainage, hardware failure, wound dehiscence)
- Bone growth factors (on blood samples from both forearms at 3 weeks after surgery)
PATIENT SELECTION
The study is directed to unstable distal radius fractures among types I, III and V, according to the classification of Fernandez (4).
It was decided to follow a group of younger patients because the outcome in older, low demand patients is not significantly dependent of a precise reduction contrary to the outcome in younger, high demand patients (15).
STUDY: PRACTICAL INFORMATION
- For each patient presenting as a candidate for the study, the inclusion and exclusion criteria should be reviewed. After informed consent, pre-operative data are collected (see case report form) and regular pre-operative data are collected to plan the operation. The patient is usually operated within one week after the injury with distal radius fracture.
- The treatment protocol of distal radius fractures relies on a decision scheme developped by Fernandez and Wolfe (21). We favored percutaneous stabilisation over open reduction and internal fixation. No significant clinical difference was noted between those two techniques in unstable fractures (22). The surgical procedure is conducted under brachial plexus anesthesia.For type I and III (4), the fracture is reduced manually with image intensifier control. One or two Kirshner wires (1.5mm) are directed from the tip of the radial styloid dorsally to the first extensor compartment at an angle of approximately 45 degrees to cross the fracture and enter the dorsoulnar cortex of the radius proximally to the fracture. These wires are placed using a power drill. An additional wire is placed into the fracture fragment, inserted into the dorsoulnar corner of the radius between the fourth and fifth extensor compartments and directed from dorsoulnarly towards palmar radially in a distal to proximal direction.6 The tips of the wires are bent and left just outside the skin, if necessary resorbable sutures (Vicryl 3/0) are used. For type III fractures (4), an external fixator bridging the joint completes usually the procedure. The criteria for reduction3 are an ulnar inclination of 22°, a palmar inclination of 11°, neutral ulnar variance and radial width (distance from the most lateral tip of the radial styloid process to the longitudinal axis through the center of the radius on an AP film). A radioscopic image of the contralateral wrist is taken in the operating room to serve as control, in the same prosupination conditions, to be standardized in the radiology department(19,20). The angles are measured preoperatively with an appropriate software (OEC radioscopy ) and controlled postoperatively with the same radioscopy software.
At the end of the surgical reduction and stabilization of the fracture, the sequentially numbered randomization envelope will be opened and the patient will receive the treatment listed within the envelope : either the ALLOMATRIX Injectable Putty or no additional graft.
- Conditions
- Radius Fractures
- Being tested
- ALLOMATRIX injectable putty in distal radius fractures
- Keywords
- radius fracture, fracture fixation, homologous bone transplantation
- Medical subject headings
- Radius Fractures
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ALLOMATRIX injectable putty in distal radius fracturesDevice
What is being measured
The primary outcome is the main question the study is designed to answer.
Hand ability: self-assesment questionnaire ABILHAND and DASH
Secondary outcomes (3)
Bone mineral density
Radiological evaluation
Hand impairment (strength, sensibilty, mobility)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Jan 2006 (estimated)
- Study startJun 2005
- Primary completionMay 2009
- Study completionMay 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Radius FracturesStudies of the same condition, open and under way.
- More trials run by Université Catholique de LouvainThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Université Catholique de Louvain
- Sponsor type
- University, hospital or other
- Collaborators
- Stryker Trauma and Extremities
- Investigators
- Olivier BARBIER, MD, Principal investigator, Cliniques Universitaires St-LUC, 1200 Brussels
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00274378
- Sponsor's protocol ID
- Allomatrix radius UCL
- Status last verified
- Jul 2009
- First submitted
- 6 Jan 2006
- Last updated
- 30 Jul 2009
- Results posted
- No
Publications
Cassidy C, Jupiter JB, Cohen M, Delli-Santi M, Fennell C, Leinberry C, Husband J, Ladd A, Seitz WR, Constanz B. Norian SRS cement compared with conventional fixation in distal radial fractures. A randomized study. J Bone Joint Surg Am. 2003 Nov;85(11):2127-37. doi: 10.2106/00004623-200311000-00010.
PubMed 14630841Barbier O, Penta M, Thonnard JL. Outcome evaluation of the hand and wrist according to the International Classification of Functioning, Disability, and Health. Hand Clin. 2003 Aug;19(3):371-8, vii. doi: 10.1016/s0749-0712(02)00150-6.
PubMed 12945633Lafontaine M, Hardy D, Delince P. Stability assessment of distal radius fractures. Injury. 1989 Jul;20(4):208-10. doi: 10.1016/0020-1383(89)90113-7.
PubMed 2592094Hollevoet N, Verdonk R. Outcome of distal radius fractures in relation to bone mineral density. Acta Orthop Belg. 2003 Dec;69(6):510-4.
PubMed 14748106
Study at a glance
From the registry record, last updated by the sponsor on 30 Jul 2009. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Allomatrix Injectable Putty in Distal Radius Fractures. Protocol for a Randomised, Controlled Clinical Study in Unstable Fractures of the Distal Radius
- ClinicalTrials.gov ID
- NCT00274378
- Acronym / sponsor ID
- Allomatrix radius UCL
- Conditions
- Radius Fractures
- Keywords
- radius fracture, fracture fixation, homologous bone transplantation
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Université Catholique de LouvainUniversity, hospital or other
- Collaborators
- Stryker Trauma and Extremities
- Study start
- Jun 2005
- Primary completion
- May 2009 (actual)
- Study completion
- May 2009 (actual)
- First posted
- 10 Jan 2006 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Allomatrix is a combination of Demineralized Bone Matrix with a binding medium of calcium sulfate hemihydrate and carboxymethylcellulose. Allomatrix combines the osteoinductive capacity of DBM with the osteoconduction and controlled resorption of surgical grade calcium sulfate.
Unstable fractures of the distal radius do not resist displacement once it has been manipulated into an anatomical position.
There is a parallel between the quality of the anatomic result and the residual capacity of the wrist, except in older, low demanding patients.
Injectable osteoconductive cements have been introduced to fill voids in metaphyseal bone and may provide a better stability around hardware in osteoporotic bone and help maintain reduction of fracture fragments.Moreover, a product like ALLOMATRIX could accelerate and improve bone healing and fracture stability by its osteoinductive properties. However, the clinical significance of these new bone graft materials still have to be proven in a randomised controlled study set-up.
Detailed description
STUDY DESIGN
The study is designed as a randomised, prospective, study with concurrent control. A total of 50 patients will be enrolled by one centre and will be randomised into two groups. One group of patients (comprising 50% of the study population) will have ALLOMATRIX Injectable Putty implanted. In a control group of patients (comprising 50% of the study population as well ) no graft material will be used.
Patients will be randomly assigned to one of the two treatment arms. Sequentially numbered randomisation envelopes will be provided. Once the surgical reduction and stabilisation has been completed, the next sequentially numbered randomisation envelope will be opened and the patient will receive the treatment listed within the envelope. Each envelope will contain one of the treatment arms based on a computer generated randomised schedule.
DURATION AND ENDPOINTS OF THE STUDY The enrollment period is expected to be about 3 years. Patients will be followed from a pre-operative visit through a one-year visit.
Study End Points:
- Comparison of time to healing of the fracture
- Comparison of function of operated wrist
- Radiographic and densitometric assessment of bone regeneration
- Failure rates (Non-union, malunion, fracture instability, wrist stiffness)
- Complication rates (infection, drainage, hardware failure, wound dehiscence)
- Bone growth factors (on blood samples from both forearms at 3 weeks after surgery)
PATIENT SELECTION
The study is directed to unstable distal radius fractures among types I, III and V, according to the classification of Fernandez (4).
It was decided to follow a group of younger patients because the outcome in older, low demand patients is not significantly dependent of a precise reduction contrary to the outcome in younger, high demand patients (15).
STUDY: PRACTICAL INFORMATION
- For each patient presenting as a candidate for the study, the inclusion and exclusion criteria should be reviewed. After informed consent, pre-operative data are collected (see case report form) and regular pre-operative data are collected to plan the operation. The patient is usually operated within one week after the injury with distal radius fracture.
- The treatment protocol of distal radius fractures relies on a decision scheme developped by Fernandez and Wolfe (21). We favored percutaneous stabilisation over open reduction and internal fixation. No significant clinical difference was noted between those two techniques in unstable fractures (22). The surgical procedure is conducted under brachial plexus anesthesia.For type I and III (4), the fracture is reduced manually with image intensifier control. One or two Kirshner wires (1.5mm) are directed from the tip of the radial styloid dorsally to the first extensor compartment at an angle of approximately 45 degrees to cross the fracture and enter the dorsoulnar cortex of the radius proximally to the fracture. These wires are placed using a power drill. An additional wire is placed into the fracture fragment, inserted into the dorsoulnar corner of the radius between the fourth and fifth extensor compartments and directed from dorsoulnarly towards palmar radially in a distal to proximal direction.6 The tips of the wires are bent and left just outside the skin, if necessary resorbable sutures (Vicryl 3/0) are used. For type III fractures (4), an external fixator bridging the joint completes usually the procedure. The criteria for reduction3 are an ulnar inclination of 22°, a palmar inclination of 11°, neutral ulnar variance and radial width (distance from the most lateral tip of the radial styloid process to the longitudinal axis through the center of the radius on an AP film). A radioscopic image of the contralateral wrist is taken in the operating room to serve as control, in the same prosupination conditions, to be standardized in the radiology department(19,20). The angles are measured preoperatively with an appropriate software (OEC radioscopy ) and controlled postoperatively with the same radioscopy software.
At the end of the surgical reduction and stabilization of the fracture, the sequentially numbered randomization envelope will be opened and the patient will receive the treatment listed within the envelope : either the ALLOMATRIX Injectable Putty or no additional graft.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- unstable distal radius fracture
Key exclusion criteria (3 listed)
- associated traumatic lesions
- associated severe pathological conditions
- pregnancy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ALLOMATRIX injectable putty in distal radius fractures | Device | – |
Primary outcome
Hand ability: self-assesment questionnaire ABILHAND and DASH
3 secondary outcomes
Bone mineral density
Radiological evaluation
Hand impairment (strength, sensibilty, mobility)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Jul 2009.
- Background: PubMed 14630841Cassidy C, Jupiter JB, Cohen M, Delli-Santi M, Fennell C, Leinberry C, Husband J, Ladd A, Seitz WR, Constanz B. Norian SRS cement compared with conventional fixation in distal radial fractures. A randomized study. J Bone Joint Surg Am. 2003 Nov;85(11):2127-37. doi: 10.2106/00004623-200311000-00010.
- Background: PubMed 12945633Barbier O, Penta M, Thonnard JL. Outcome evaluation of the hand and wrist according to the International Classification of Functioning, Disability, and Health. Hand Clin. 2003 Aug;19(3):371-8, vii. doi: 10.1016/s0749-0712(02)00150-6.
- Background: PubMed 2592094Lafontaine M, Hardy D, Delince P. Stability assessment of distal radius fractures. Injury. 1989 Jul;20(4):208-10. doi: 10.1016/0020-1383(89)90113-7.
- Background: PubMed 14748106Hollevoet N, Verdonk R. Outcome of distal radius fractures in relation to bone mineral density. Acta Orthop Belg. 2003 Dec;69(6):510-4.
Related trials for Radius Fractures
Not yet recruiting
Magnesium Alloy Scaffold With Controlled Degradation for Periarticular Bone Defects
Periarticular Bone Defect, Proximal Humerus Fracture
RecruitingPhase 1
Impact of Early ADL Education on Outcomes Post DRF ORIF
Distal Radius Fractures
Recruiting
Optimal Duration of Longitudinal Mechanical Traction in Displaced Radius Fractures: a Prospective Non-inferiority Study
Distal Radius Fracture
Recruiting
Home-Based Photobiomodulation Effects in the Postoperative Period of Distal Radius Fractures
Distal Radius Fracture
Not yet recruiting
X-BS Ortho Bone Graft Study
Orthopedic Disorder, Trauma Injury
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Olivier BARBIER, MD principal investigator
Cliniques Universitaires St-LUC, 1200 Brussels
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing ALLOMATRIX injectable putty in distal radius fractures in people with Radius Fractures, run by Université Catholique de Louvain at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Jul 2009. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Hand ability: self-assesment questionnaire ABILHAND and DASH. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00274378, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2009.